In summary, these results indicate that the synergistic inhibition of tumor growth by the HF-ATS combination is associated with the increased levels of p21Cip1 and p27Kip1 and the decreased phosphorylation of CDK2. The gene discussed is CDKN1A; the disease is neoplasm.